Volume 143, Issue 5 p. 626-632
Original Research–Sinonasal Disorders

The utility of intrathecal fluorescein in cerebrospinal fluid leak repair

Rahul Seth MD

Corresponding Author

Rahul Seth MD

Head and Neck Institute, Cleveland Clinic, Cleveland, OH

Corresponding author: Rahul Seth, MD, Head and Neck Institute, Department of Otolaryngology–Head and Neck Surgery, Cleveland Clinic, 9500 Euclid Avenue, Desk A71, Cleveland, OH 44195. E-mail address: [email protected].Search for more papers by this author
Karthik Rajasekaran

Karthik Rajasekaran

Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, IL

Search for more papers by this author
Michael S. Benninger MD

Michael S. Benninger MD

Head and Neck Institute, Cleveland Clinic, Cleveland, OH

Search for more papers by this author
Pete S. Batra MD

Pete S. Batra MD

Department of Otolaryngology–Head and Neck Surgery and Comprehensive Skull Base Program, University of Texas Southwestern Medical Center, Dallas, TX

Search for more papers by this author
First published: 01 November 2010
Citations: 3

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Abstract

OBJECTIVE

To evaluate the utility of intrathecal fluorescein (IF) for intraoperative localization and successful repair of cerebrospinal fluid (CSF) leaks.

STUDY DESIGN

Case series with chart review.

SETTING

Tertiary-care medical center.

SUBJECTS AND METHODS

Subjects included those undergoing endoscopic CSF leak repair with or without the use of IF. Informed consent was obtained from all patients undergoing the administration of IF (total dose 10 mg).

RESULTS

A total of 103 patients underwent CSF leak repair, and in 47 cases (45.6%), IF was used. Patients who were administered IF were more likely to have spontaneous CSF leak etiology (61.7% vs 16.1%; P < 0.001). Of the 47 cases with IF use, fluorescein was visualized at the skull base in 31 cases (66.0%), 11 (23.4%) had visible CSF leak without fluorescein coloration, and five (10.6%) had neither clear nor fluorescein-colored CSF visualized. Sensitivity and specificity for fluorescein detection was 73.8 percent (95% confidence interval [CI] 57.7%-85.6%) and 100 percent (95% CI 46.3%-100%), respectively. The false-negative rate was 26.2 percent (95% CI 15.8%-43.5%). Localization of the leak site was greater when fluorescein-colored CSF was visualized (100% vs 81.3%; P = 0.035). When fluorescein-colored CSF was not visualized intraoperatively, recurrence rates were 31.3 percent versus 9.7 percent when fluorescein coloration was seen, although this finding was not statistically significant (P = 0.10).

CONCLUSION

The use of IF facilitates the accurate localization of CSF leaks and may assist the surgeon in confirming a watertight closure. The lack of intraoperative fluorescein visualization should not rule out the presence of CSF leak, as evidenced by a false-negative rate of 26.2 percent.